EMA: Benefit of AstraZeneca’s COVID Vaccine Outweighs Risk, for Now

Amid ongoing concern about reports of thromboembolic events occurring in European Union (EU) residents who have received AstraZeneca’s COVID-19 vaccine, the executive director of the European Medicines Agency (EMA) said that the “benefit to risk ratio remains positive” for the vaccine, and that Europeans should continue to receive the vaccine […]